Stroke prevention device misses key goal in study

by Marilynn Marchione

The future is unclear for a promising heart device aimed at preventing strokes in people at high risk of them because of an irregular heartbeat.

Early results from a key study of Boston Scientific Corp.'s Watchman device suggest it is safer than previous testing suggested, but may not be as good as a drug that is used now for preventing strokes, heart-related deaths and in people with atrial . That condition causes the heart to flutter rather than beat as it should, which can lead to clots that cause strokes.

The results were to have been the top study at an American College of Cardiology conference in San Francisco on Saturday but the presentation was pulled because the company released results early.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Stroke-preventing technology demonstrated in JoVE

Feb 28, 2012

In the United States alone, approximately 6 million people suffer from an irregular heartbeat called atrial fibrillation (AF), and since the incidence increases with age, it is predicted that 15.9 million ...

FDA clears anticlotting drug Eliquis

Dec 28, 2012

The Food and Drug Administration says it has approved the anticlotting drug Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc. It's a potential blockbuster drug in a new category of medicines to prevent strokes ...

Recommended for you

ASHG: MI without substantial CAD is minimally heritable

Oct 21, 2014

(HealthDay)—The presence of myocardial infarction (MI) without substantial coronary artery disease (CAD) is not familial, according to a study presented at the annual meeting of the American Society of ...

User comments